Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

被引:641
作者
Bryceson, YT
March, ME
Ljunggren, HG
Long, EO
机构
[1] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA
[2] Karolinska Univ, Hosp Huddinge, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden
关键词
D O I
10.1182/blood-2005-04-1351
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Freshly isolated, resting natural killer (NK) cells are generally less lytic against target cells than in vitro interleukin 2 (IL-2)activated INK cells. To investigate the basis for this difference, the contribution of several receptors to activation of human NK cells was examined. Target-cell lysis by IL-2-activated NK cells in a redirected, anti body-dependent cytotoxicity assay was triggered by a number of receptors. In contrast, cytotoxicity by resting NK cells was induced only by CD16, and not by NKp46, NKG2D, 2134 (CD244), DNAM-1 (CD226), or CD2. Calcium flux in resting NK cells was induced with antibodies to CD16 and, to a weaker extent, antibodies to NKp46 and 2B4. Although NKp46 did not enhance CD16-mediated calcium flux, it synergized with all other receptors. 2B4 synergized with 3 other receptors, NKG2D and DNAM-1 each synergized with 2 other receptors, and CD2 synergized with NKp46 only. Resting NK cells were induced to secrete tumor necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma), and to kill target cells by engagement of specific, pair-wise combinations of receptors. Therefore, natural cytotoxicity by resting NK cells is induced only by mutual costimulation of nonactivating receptors. These results reveal distinct and specific patterns of synergy among receptors on resting NK cells.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 67 条
[1]   Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors [J].
André, P ;
Castriconi, R ;
Espéli, M ;
Anfossi, N ;
Juarez, T ;
Hue, S ;
Conway, H ;
Romagné, F ;
Dondero, A ;
Nanni, M ;
Caillat-Zucman, S ;
Raulet, DH ;
Bottino, C ;
Vivier, E ;
Moretta, A ;
Paul, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (04) :961-971
[2]   The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46 [J].
Arnon, TI ;
Achdout, H ;
Lieberman, N ;
Gazit, R ;
Gonen-Gross, T ;
Katz, G ;
Bar-Ilan, A ;
Bloushtain, N ;
Lev, M ;
Joseph, A ;
Kedar, E ;
Porgador, A ;
Mandelboim, O .
BLOOD, 2004, 103 (02) :664-672
[3]   The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse [J].
Badour, K ;
Zhang, JY ;
Shi, F ;
McGavin, MKH ;
Rampersad, V ;
Hardy, LA ;
Field, D ;
Siminovitch, KA .
IMMUNITY, 2003, 18 (01) :141-154
[4]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[5]   Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation [J].
Betts, MR ;
Brenchley, JM ;
Price, DA ;
De Rosa, SC ;
Douek, DC ;
Roederer, M ;
Koup, RA .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 281 (1-2) :65-78
[6]   NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway [J].
Billadeau, DD ;
Upshaw, JL ;
Schoon, RA ;
Dick, CJ ;
Leibson, PJ .
NATURE IMMUNOLOGY, 2003, 4 (06) :557-564
[7]   FC RECEPTOR STIMULATION OF PHOSPHATIDYLINOSITOL 3-KINASE IN NATURAL-KILLER-CELLS IS ASSOCIATED WITH PROTEIN-KINASE C-INDEPENDENT GRANULE RELEASE AND CELL-MEDIATED CYTOTOXICITY [J].
BONNEMA, JD ;
KARNITZ, LM ;
SCHOON, RA ;
ABRAHAM, RT ;
LEIBSON, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1427-1435
[8]   Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells [J].
Bottino, C ;
Moretta, L ;
Pende, D ;
Vitale, M ;
Moretta, A .
MOLECULAR IMMUNOLOGY, 2004, 41 (6-7) :569-575
[9]   Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule [J].
Bottino, C ;
Castriconi, R ;
Pende, D ;
Rivera, P ;
Nanni, M ;
Carnemolla, B ;
Cantoni, C ;
Grassi, J ;
Marcenaro, S ;
Reymond, N ;
Vitale, M ;
Moretta, L ;
Lopez, M ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (04) :557-567
[10]   2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 [J].
Brown, MH ;
Boles, K ;
van der Merwe, PA ;
Kumar, V ;
Mathew, PA ;
Barclay, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2083-2090